Proteomics for the identification of specifically oxidized proteins in brain: Technology and application to the study of neurodegenerative disorders

Amino Acids

Volumn 25, Issue 3-4, 2003, Pages 419-425

  Butterfield, D A ^a   Castegna, A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Neurodegeneration; Oxidized proteins; Proteomics

Indexed keywords

GENE PRODUCT;

ALZHEIMER DISEASE; BRAIN; DEGENERATIVE DISEASE; EVIDENCE BASED MEDICINE; GENE SEQUENCE; GENOME; NEUROPATHOLOGY; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEOMICS; REGULATORY MECHANISM; REVIEW;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN CHEMISTRY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; PROTEINS; PROTEOMICS;

EID: 0346100510     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-003-0027-7     Document Type: Review

References (28)

1. Abbot A (1999) A post-genomic challenge: learning to read patterns of protein synthesis. Nature 402: 715-720
2. Aebersold R, Goodlett DR (2001) Mass spectrometry in proteomics. Chem Rev 101: 269-295
3. Aksenov M, Aksenova M, Butterfield DA, Markesbery WR (2000) Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem 74: 2520-2527
4. Anderson JS, Seilhamer J (1997) A comparison of selected mRNA and protein abundanced in human liver. Electrophoresis 18: 533-537
5. Beckman JS (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844
6. Bobrowski K, Pogocki KD, Schöneich C (1998) Oxidation of (carboxyalkyl)thiopropionic acid derivatives by hydroxyl radicals. Mechanisms and kinetics of competitive inter- and intramolecular formation σ- of and σ*-type sulfuranyl radicals. J Phys Chem 102: 10512-10521
7. Butterfield DA, Lauderback CM (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic Biol Med 32: 1050-1060
8. Butterfield DA, Stadtman ER (1997) Protein oxidation processes in aging brain. Adv Cell Aging Gerontol 2: 161-191
9. Butterfield DA, Drake J, Pocernich C, Castegna A (2001) Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 7: 548-554
10. Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Review: Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contributes to neuronal death. Neurobiol Aging 23: 655-664
11. Butterfield DA, Boyd-Kimball D, Castegna A (2003) Proteomics in Alzheimer's disease: Insights into mechanisms of neurodegeneration. J Neurochem (in press)
12. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA (2002a) Proteomic identification of oxidatively modified proteins in alzheimer's disease brain. part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33: 562-571
13. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA (2002b) Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase- related protein 2, α-enolase and heat shock cognate 71. J Neurochem 82: 1524-1532
14. Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA (2003) Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 85: 1394-1401
15. Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW (2002) Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun. 293: 1566-1570
16. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128
17. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999
18. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, Lovell M, Markesbery WR, Butterfield DA (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65: 2146-2156
19. Korolainen MA, Goldsteins G, Alafuzoff I, Koistinaho J, Pirttila T (2002) Proteomic analysis of protein oxidation in Alzheimer's disease brain. Electrophoresis. 23: 3428-3433
20. Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Markesbery WR, Butterfield DA (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Aβ1-42. J Neurochem 78: 413-416
21. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvic BM, Yates III JR (1997) Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol 17: 676-682
22. Markesbery WR, Lovell MA (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19: 33-36
23. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP (1997) Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 17: 1046-1054
24. Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, Stadtman ER (2001) Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci USA 98: 12920-12925
25. Opiteck GJ, Lewis C, Jorgenson JW, Anderegg RJ (1997) Comprehensive on-line LC/LC/MS of proteins. Anal Chem 69: 1518-1524
26. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G (1997) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17: 2653-2657
27. Tilleman K, Stevens I, Spittaels K, Haute CV, Clerens S, Van Den Bergh G, Geerts H, Van Leuven F, Vandesande F, Moens L (2002a) Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view. Proteomics 2: 94-104
28. Tilleman K, Van Den Haute C, Geerts H, Leuven Fv F, Esmans EL, Moens L (2002b) Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice. Proteomics 2: 656-665